Losartan Potassium Tablets, USP 100 mg, [90 or 1000] tablets per bottle, Rx Only, Manufactured fo...

FDA Drug Recall #D-0122-2020 — Class II — September 19, 2019

Recall Summary

Recall Number D-0122-2020
Classification Class II — Moderate risk
Date Initiated September 19, 2019
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Torrent Pharma Inc.
Location Basking Ridge, NJ
Product Type Drugs
Quantity 39,432 bottles

Product Description

Losartan Potassium Tablets, USP 100 mg, [90 or 1000] tablets per bottle, Rx Only, Manufactured for: Torrent Pharma Inc., Basking Ridge, NJ 07920. NDC 90 tablets: 13668-115-90; NDC 1000 tablets: 13668-115-10

Reason for Recall

CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level of 9.82 parts per million.

Distribution Pattern

Nationwide USA and Puerto Rico

Lot / Code Information

Count, lot, expiry: [90 count] Lot 4DU3E009, exp 12/31/2020; [1000 count] Lot 4DU3D018, exp 02/28/2021

Other Recalls from Torrent Pharma Inc.

Recall # Classification Product Date
D-0455-2025 Class II Fluoxetine Tablets, USP, 20 mg, 30-count bottl... May 27, 2025
D-0456-2025 Class II Fluoxetine Tablets, USP, 20 mg, 28-count Carton... May 27, 2025
D-0365-2022 Class II Carbamazepine Tablets, USP 200 mg 100 Tablets R... Dec 2, 2021
D-0285-2022 Class III Telmisartan and Hydrochlorothiazide Tablets, US... Dec 1, 2021
D-1317-2020 Class II Carbamazepine Tablets, USP 200 mg, packaged in ... May 11, 2020

Frequently Asked Questions

cGMP stands for Current Good Manufacturing Practice — the FDA's regulations governing drug manufacturing quality. A cGMP recall means the company failed to follow required manufacturing standards. This could involve inadequate testing, poor environmental controls, documentation failures, or process deviations. cGMP recalls do not always mean the product is directly harmful — in many cases, quality records are insufficient to confirm the product meets specifications. However, the FDA requires a recall because without proper documentation, product quality cannot be assured. These are often Class II or Class III recalls.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.